Privia Health board classified into three staggered classes after lead investors' stake falls below 25%

Privia Health Group, Inc.

Lead Investors Goldman Sachs and Pamplona completed secondary offering on May 8, 2023, reducing combined ownership below 25% voting power.
Board now divided into three classes with staggered three-year terms effective May 9, 2023.
Class I (term expires 2023): Jeff Bernstein, Nancy Cocozza, David King.
Class II (term expires 2024): Thomas McCarthy, Jaewon Ryu, Bill Sullivan.
Class III (term expires 2025): Patricia Maryland, Shawn Morris, Will Sherrill.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.